Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Compumedics Limited

Market Cap 50.44M 35.37M 30.85M 28.54M 26.77M 50.11M 3.34B 339M 131M 1.64B 133M 130M 5.7B P/E 2026 *
16.8x
P/E 2027 * 6.82x
Enterprise Value 50.44M 35.37M 30.85M 28.54M 26.77M 50.11M 3.34B 339M 131M 1.64B 133M 130M 5.7B EV / Sales 2026 *
0.76x
EV / Sales 2027 * 0.63x
Free-Float
36.04%
Yield 2026 *
-
Yield 2027 * 7.92%
1 day-6.48%
1 week+5.21%
Current month-6.48%
1 month-9.82%
3 months-12.93%
6 months-34.42%
Current year-24.63%
1 week 0.24
Extreme 0.24
0.28
1 month 0.24
Extreme 0.24
0.28
Current year 0.24
Extreme 0.24
0.45
1 year 0.24
Extreme 0.24
0.45
3 years 0.15
Extreme 0.15
0.45
5 years 0.14
Extreme 0.135
0.49
10 years 0.14
Extreme 0.135
0.96
Manager TitleAgeSince
Chief Executive Officer 67 15/12/2010
Director of Finance/CFO 61 10/11/2009
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 67 15/12/2010
Director/Board Member 61 31/12/1999
Director/Board Member - 26/10/2022
Change 5-day change 1-year change 3-year change Capi.($)
-6.48%+5.21%-2.88%+36.49% 35.36M
+0.63%-1.01%+16.77%-11.91% 173B
+1.14%-1.04%-20.14%+24.08% 144B
-0.33%-1.63%-9.79%-25.12% 125B
+0.76%-3.45%-55.29%-16.19% 67.32B
+0.78%+2.64%+18.33%-4.95% 50.3B
-0.58%-1.16%-25.96%-32.99% 43.8B
+2.20%-2.14%+9.95%+7.53% 35.89B
-0.44%-0.03%+3.74%+35.01% 34.9B
+0.72%-5.51%-13.59%-21.94% 28.02B
Average -0.16%-1.15%-7.89%-1.00% 70.24B
Weighted average by Cap. +0.54%-1.89%-7.21%-5.18%

Financials

2026 *2027 *
Net sales 66.3M 46.49M 40.55M 37.51M 35.19M 65.87M 4.39B 446M 173M 2.16B 175M 171M 7.5B 79.7M 55.88M 48.74M 45.09M 42.3M 79.18M 5.27B 536M 207M 2.6B 210M 205M 9.01B
Net income 3.8M 2.66M 2.32M 2.15M 2.02M 3.78M 251M 25.54M 9.89M 124M 10M 9.79M 430M 9M 6.31M 5.5M 5.09M 4.78M 8.94M 595M 60.48M 23.42M 293M 23.69M 23.19M 1.02B
Net Debt - -
Logo Compumedics Limited
Compumedics Limited is an Australia-based medical device company which is involved in the development, manufacture, and commercialization of diagnostics technology for sleep, brain and ultrasonic blood flow monitoring applications. Its geographic segments include the Americas, Australia and Asia Pacific, and Europe and the Middle East. It sells all of its product offerings in this region, including sleep diagnostic systems, clinical electroencephalograms (EEG systems), brain monitoring systems, ultrasonic blood-flow systems, supplies and technical service and support. It provides Sleep Diagnostics and Neurology Diagnostics Solutions. Its products include Compumedics Siesta, Compumedics Somfit, Compumedics Somte PSG and others. It provides a range of solutions for the neurology laboratory, from clinical epilepsy monitoring applications to Transcranial Doppler Sonography. Its other products include Grael 4K PSG, Falcon HST, Okti, Neuvo 64-512 Channel LTM EEG and others.
Employees
175
Date Price Change Volume
19/06/26 0.2525 $ -6.48% 108,755
18/06/26 0.2700 $ +1.89% 85,386
17/06/26 0.2650 $ +8.16% 9,416
16/06/26 0.2450 $ 0.00% 70,083
15/06/26 0.2450 $ +2.08% 249,591
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2525AUD
Average target price
0.8000AUD
Spread / Average Target
+216.83%

Annual profits - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!